Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coccidian mitochondrial and replication-associated targets refer to a group of essential biochemical pathways and enzymes in protozoan parasites of the subclass Coccidia, including Eimeria, Toxoplasma, and Cryptosporidium. These targets are critical for the parasite's energy production and genetic continuity (Vaidya & Mather, 2009). Mitochondrial targets primarily include the cytochrome bc1 complex (Complex III), which is vital for the electron transport chain and linked to pyrimidine biosynthesis via dihydroorotate dehydrogenase. Replication-associated targets include enzymes such as dihydrofolate reductase (DHFR) and thymidylate synthase, which are necessary for synthesizing the DNA precursors required for rapid parasite multiplication (Roos, 1993). Drugs like atovaquone and decoquinate act by binding to the cytochrome b subunit, leading to a collapse of the mitochondrial membrane potential (Kessl et al., 2004). Meanwhile, antifolate drugs like pyrimethamine inhibit DNA replication by targeting the DHFR-TS complex. These targets are central to the development of anticoccidial agents used in both veterinary and human medicine, though their clinical utility is often limited by the rapid emergence of resistant strains harboring specific genetic mutations (Fry & Williams, 1984).
Inhibition of the mitochondrial cytochrome bc1 complex (Complex III) to disrupt electron transport and pyrimidine biosynthesis, and inhibition of the dihydrofolate reductase-thymidylate synthase (DHFR-TS) system to prevent DNA replication.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coccidian mitochondrial and replication-associated targets.